Printing the Future of Therapeutics in 3D
May 6-8, 2019
Peter Wall Institute for Advanced Studies
Vancouver, BC, Canada
FOSTERING RELATIONSHIPS AND DEVELOPING COLLABORATIONS
PFT3D is an exclusive roundtable event centered around facilitating discussion and collaboration on the development of commercially and clinically relevant life-saving tissues.
ROUNDTABLE INFORMATION
Aspect Biosystems and The University of British Columbia are proud to be co-organizing the third annual International Research Roundtable on Printing the Future of Therapeutics in 3D (PFT3D).
Last year’s inaugural event saw speakers from a wide variety of both academia and industry to discuss the amazing potential and applications of 3D bioprinting. This year, the roundtable will take place over 3 days and includes 17 speakers, covering four key areas:
Functional biofabricated tissues for disease modeling, therapeutic discovery, and regenerative medicine
Platform technologies to recreate biological function
Biomaterials for the development of functional tissues
An industry perspective on tissue engineering technologies
By the end of this meeting, we want you to leave with new inspirational ideas on groundbreaking projects, new partners and opportunities for collaboration, and a fresh perspective on the needs of industry and the translation of academic research.
In addition to our roundtable talks, there will be focused discussion sessions to address a variety of key challenges in our industry and facilitated networking sessions to stimulate interactions.
2018 SPEAKERS
(2019 coming soon…)
Organizing Committee
Tamer Mohamed
President & CEO, Aspect Biosystems
Christian Naus
Professor, University of British Columbia
Sam Wadsworth
Chief Scientific Officer, Aspect Biosystems
Natalie Korenic
Marketing & Communications Manager, Aspect Biosystems
Speakers
Elizabeth Aisenbrey
Postdoctoral Trainee in Vascular Surgery and Biomedical Engineering, University of Wisconsin
David Ballard
Radiology Resident, Mallinckrodt Institute of Radiology, Washington University School of Medicine
Andreas R. Baudy
Assoc. Principal Scientist, Safety Assessment Department, Merck & Co., Inc
Robert A. Blake
Scientist in Biochemical and Cellular Pharmacology, Genentech, Inc.
Akhilesh K. Gaharwar
Assistant Professor of Biomedical Engineering, Texas A&M University
Sepideh H. Hagvall
Associate Principal Scientist, AstraZeneca and Adjunct Professor in Molecular Biology, Skövde University, Sweden
Jeremy Hirota
Canada Research Chair in Respiratory Mucosal Immunology, Assistant Professor of Medicine - McMaster University, Assistant Professor of Medicine (Affiliate) - UBC
Jinah Jang
Assistant Professor, Pohang University of Science and Technology (POSTECH)
Anna Jezierski
Research Scientist, Human Health Therapeutics, National Research Council Canada
Jean-Louis Klein
Director, Target & Pathway Validation, GlaxoSmithKline
Tamer Mohamed
President & CEO, Aspect Biosystems
John F. Trant
Assistant Professor, Department of Chemistry and Biochemistry and the Canadian Centre for Alternatives to Animal Methods, University of Windsor
Stephanie Willerth
Associate Professor and Canada Research Chair in Biomedical Engineering, University of Victoria
Bill Yackabonis
Technical Manager, Autodesk
Peter Zandstra
Director, School of Biomedical Engineering and Professor, Department of Medical Genetics, UBC
Boyang Zhang
Assistant Professor, Department of Chemical Engineering, McMaster University
Yu Shrike Zhang
Associate Bioengineer and Faculty, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
2017 SPEAKERS
- Mohsen Akbari
Assistant Professor, University of Victoria - Joseph M. Ault
Senior Fellow, API and Bioprinting, 3D Printing Center of Excellence, Johnson and Johnson Services Inc. - Danny Cabrera
CEO, BioBots - Pieter Cullis
Director, Life Sciences Institute, University of British Columbia - Gráinne Cunniffe
Senior Research Fellow, Trinity College Dublin, Ireland - Albert Folch
Associate Professor, University of Washington - Axel Guenther
Associate Professor, University of Toronto - Dan Huh
Assistant Professor, University of Pennsylvania
- John Hornick
Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. - Claire Jeong
Investigator, Complex In Vitro Models, GSK - Keekyoung Kim
Assistant Professor, University of British Columbia Okanagan Campus - Tamer Mohamed
President & CEO, Aspect Biosystems - Koichi Nakayama
Chairman, Saga University, Japan - Julie Robillard
Assistant Professor, University of British Columbia - Fabio Rossi
Acting Director, The Biomedical Research Centre, University of British Columbia - Wun Chey Sin
Research Associate, University of British Columbia
- Sam Wadsworth
CSO, Aspect Biosystems - Konrad Walus
CTO, Aspect Biosystems - Stephanie Willerth
Associate Professor, University of Victoria and Acting Director, Centre for Biomedical Research - Vikram Yadav
Assistant Professor, University of British Columbia - Peter Zandstra
CSO, Centre for Commercialization of Regenerative Medicine - Marcy Zenobi-Wong
Professor, ETH Zurich, Switzerland - Boyang Zhang
Postdoctoral Fellow, University of Toronto - Yu Shrike Zhang
Instructor of Medicine and Associate Bioengineer, Harvard Medical School
VENUE & HOSTS
We are proud to be hosting this International Research Roundtable at the Peter Wall Institute for Advanced Studies on the beautiful University of British Columbia (UBC) campus in Vancouver, BC.
The Peter Wall Institute for Advanced Studies at the University of British Columbia (UBC) provides funding opportunities and an intellectual environment scholars are free to pursue the collaborative exchange of ideas beyond disciplinary boundaries.
The Institute’s goal is to stimulate creative, innovative research that makes important advances in knowledge, and to share or implement these ideas through ongoing community engagement. The Institute achieves this by supporting a highly collaborative environment at UBC where scholars have the opportunity to exchange ideas with national and international scholars, develop new thinking and engage in intellectual risk-taking.
The University of British Columbia is a global centre for research and teaching, consistently ranked among the 40 best universities in the world. Since 1915, UBC’s West Coast spirit has embraced innovation and challenged the status quo. Its entrepreneurial perspective encourages students, staff and faculty to challenge convention, lead discovery and explore new ways of learning. At UBC, bold thinking is given a place to develop into ideas that can change the world.
Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. The company’s proprietary Lab-on-a-Printer™ platform technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate the discovery and development of new drugs and therapies.
2018 SPONSORS
Thank you to our sponsors. Please contact us if you are interested in sponsorship opportunities.
